Skip to main content
. Author manuscript; available in PMC: 2018 Feb 21.
Published in final edited form as: Circulation. 2016 Dec 14;135(8):741–754. doi: 10.1161/CIRCULATIONAHA.116.024921

Table 1.

Baseline Characteristics Study Cohorts

AGES
(n=2953)
ARIC
(n=9276)
FHS
(n=7509)
PREVEND
(n=3515)
RS-I
(n=5729)
RS-II
(n=2087)
WGHS
(n=20577)
Age, years 76 (5) 54 (6) 51 (15) 49 (12) 69 (9) 65 (8) 54 (7)
Men 1341 (42%) 4356 (47%) 3459 (46%) 1809 (51%) 2302 (40%) 949 (46%) -
Height, cm 167 (9) 169 (9) 169 (10) 174 (9) 167 (9) 170 (9) 164 (6)
Current cigarette smoking 378 (13%) 2293 (25%) 1183 (16%) 1235 (35%) 1324 (23%) 470 (23%) 2315 (11%)
Body mass index, kg/m2 27.1 (4.4) 27.0 (4.9) 27.0 (5.1) 26.1 (4.2) 26.3 (3.7) 27.2 (4.0) 25.9 (4.9)
SBP, mmHg 143 (20) 118 (17) 123 (18) 129 (20) 139 (22) 143 (21) 123 (14)
DBP, mmHg 74 (10) 72 (10) 75 (10) 74 (10) 74 (11) 79 (11) 77 (9)
Hypertensive medication 1834 (62%) 2344 (25%) 1578 (21%) 416 (14%) 1730 (30%) 566 (27%) 2610 (13%)
Diabetes mellitus 326 (11%) 795 (9%) 443 (6%) 133 (4%) 571 (10%) 219 (11%) 497 (2%)
Previous heart failure 49 (2%) 334 (4%) 40 (0.5%) 6 (0.2%) 139 (2%) 18 (1%) -
Previous coronary heart disease 495 (17%) 454 (5%) 419 (6%) 28 (1%) 431 (8%) 128 (6%) -
EtOH Consumption ≥ 2 drinks/day 23 (1%) 594 (6%) 7243 (96%)* 943 (27%) 916 (16%) 390 (19%) 838 (4%)
Body mass index gene score 4.1 (0.5) 4.1 (0.5) 4.1 (0.5) 4.1 (0.5) 4.1 (0.5) 4.1 (0.5) 4.1 (0.5)
FTO variant (rs1558902) CAF, % 40 41 42 40 38 40 41
# Atrial fibrillation cases 422 (14%) 1373 (15%) 555 (7%) 113 (3%) 693 (12%) 80 (4%) 942 (5%)
Mean follow-up time, years 7.4 (2.5) 19.2 (5.5) 8.4 (3.2) 9.6 (2.3) 12.7 (5.7) 8.4 (1.9) 18.0 (3.3)
Baseline years 2002-2006 1987-1989 1987-2007 1997-1998 1990-93 2000-01 1992 - 1995
End of follow-up 2012 2010 2011 2008 2010 2010 2011

Values correspond to N (%) or mean (standard deviation). Body mass index (BMI) gene score reflects a weighted sum of BMI increasing alleles of 39 single nucleotide polymorphisms (see Methods).

*

>0 drinks/day;

≥1 drink/day.

AGES, indicates the Age, Gene/Environment Susceptibility—Reykjavik study; ARIC, Atherosclerosis Risk in Communities; FHS, Framingham Heart Study; PREVEND, Prevention of Renal and Vascular End-Stage Disease; RS, Rotterdam Study; WGHS, Women's Genome Health Study; SBP, systolic blood pressure; DBP, diastolic blood pressure; EtOH, alcohol; CAF, coded allele frequency for FTO SNP (rs1558902) associated with increasing body mass index.